Recommended INN - List 66
rINN
amatuximab
asfotase alfa
atinumab
carlumab
egaptivon pegol
elsiglutide
enavatuzumab
enokizumab
etrolizumab
fulranumab
gevokizumab
icrucumab
mogamulizumab
namilumab
onartuzumab
plecanatide
ponezumab
radretumab
simoctocog alfa
tregalizumab
turoctocog alfa
ublituximab
urelumab
vesencumab
▲
